Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer

NCT01914900 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Resectable Oral Cavity Squamous Cell Cancer

Interventions

DRUG: docetaxel, cisplatin, 5 fluorouracil

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano